Aurdan Capital Management’s Merck MRK Stock Holding History

Aurdan Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Sell	8,418 -1,510	-15%	-$177K	0.27%	43
2026 Q1	$1.19M	Buy	9,928 +1,807	+22%	+$209K	0.36%	40
2025 Q4	$855K	Hold	8,121	–	–	0.26%	47
2025 Q3	$682K	Sell	8,121 -19	-0.2%	-$1.56K	0.22%	53
2025 Q2	$644K	Sell	8,140 -1,981	-20%	-$157K	0.22%	57
2025 Q1	$908K	Hold	10,121	–	–	0.34%	46
2024 Q4	$1.01M	Buy	+10,121	New	+$1.04M	0.39%	44

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Aurdan Capital Management's MRK Position: Q2 2026 in Review

Aurdan Capital Management reduced its Merck (MRK) stake by 15% in Q2 2026, selling an estimated $177K and leaving 8,418 shares worth $1.08M. The position accounts for 0.27% of the portfolio, ranked #43.

Aurdan Capital Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Aurdan Capital Management held 8,418 shares of Merck worth $1.08M as of Q2 2026.
Aurdan Capital Management sold 1,510 Merck shares in Q2 2026, an estimated $177K.
Merck made up 0.27% of Aurdan Capital Management's portfolio in Q2 2026, its #43 holding.
Aurdan Capital Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
Aurdan Capital Management's Merck position peaked at $1.19M in Q1 2026.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.